A health impact assessment published in Environmental Science and Ecotechnology shows that China's tightened annual fine particulate matter (PM2.5) standard could substantially reduce premature deaths and move the country closer to the World Health Organization's 2040 goal of halving air-pollution-related mortality.
The study, led by researchers at Peking University Health Science Center and the Chinese Academy of Environmental Planning, estimates that full compliance with the revised 25 micrograms per cubic meter (µg/m³) standard would have averted 233,668 premature deaths in 2024, a 16.1% reduction from observed levels. By comparison, the former 35 µg/m³ limit would have averted only 53,985 deaths, meaning the stricter standard delivers about 4.3 times the health benefit.
China revised its National Ambient Air Quality Standards in 2026 to 25 µg/m³, with an interim 30 µg/m³ phase from 2026 to 2030. The move follows a decade of clean air actions that cut population-weighted PM2.5 exposure from 62.8 to 29.7 µg/m³ between 2013 and 2024. The new limit aligns China more closely with major economies and WHO guidelines, and supports the country's Beautiful China Initiative target of below 25 µg/m³ by 2035.
Health gains are strongly disease-specific. Under the 25 µg/m³ scenario, mortality fell by 22.8% for chronic obstructive pulmonary disease (COPD), 18.4% for stroke, 18.4% for lung cancer, 18.0% for lower respiratory infections, and 16.0% for ischemic heart disease. Reductions were only 1.4% for dementia and 1.1% for type 2 diabetes mellitus, and the dementia estimate requires caution because evidence is weaker. Nationally, the PM2.5-attributable fraction of mortality fell from 32.5% in 2015 to 22.6% in 2024.
Full compliance with the 35, 30, and 25 µg/m³ standards would increase PM2.5-specific progress toward the WHO halving target to 66.2%, 72.6%, and 83.4%, respectively. COPD would exceed the 50% halving benchmark under the 25 µg/m³ scenario, whereas dementia and type 2 diabetes would remain far behind. A sensitivity analysis using the Global Exposure Mortality Model showed a similar pattern, with 3.9 times more deaths averted under 25 than 35 µg/m³.
The findings have direct policy implications. The authors argue that policymakers should prioritize regions with large populations and high PM2.5 exposure, where compliance with 25 µg/m³ would yield the largest gains, and pair air-quality control with older-adult protection, clinical prevention, and chronic-disease management. Because abatement costs are rising and population aging can offset exposure-related gains, future standards should be evaluated by disease-specific health returns, not compliance rates alone.
The study, available at 10.1016/j.ese.2026.100781, also offers a framework that could inform other developing countries seeking to tighten PM2.5 limits while tracking progress toward the WHO 2040 halving target.


